EU GMP Chapter 4 documentation – Pharma GMP

Risk Assessment Guide for Illegible or Smudged Records

digi — Fri, 14 Nov 2025 10:42:28 +0000

Risk Assessment Guide for Illegible or Smudged Records Risk Assessment for Illegible or Smudged GMP Records Introduction: Why This Topic Matters for GMP Compliance Legibility of GMP records is more than a clerical requirement—it is a regulatory necessity. Records that are smudged, faded, or illegible undermine data integrity and can prevent regulators from verifying compliance...

Why Duplicate Records Can Invalidate Your Entire Batch

digi — Fri, 14 Nov 2025 10:42:24 +0000

Why Duplicate Records Can Invalidate Your Entire Batch The Compliance Risks of Duplicate Records in GMP Documentation Introduction: Why This Topic Matters for GMP Compliance Duplicate records in GMP environments raise serious concerns about data integrity and transparency. Whether intentional or accidental, duplicate batch records, logbooks, or laboratory data can create confusion about which record...

How to Justify Missing Signatures in a GMP Investigation

digi — Sun, 14 Sep 2025 01:23:12 +0000

How to Justify Missing Signatures in a GMP Investigation Justifying Missing Signatures in GMP Investigations Introduction: Why This Topic Matters for GMP Compliance In pharmaceutical manufacturing, every signature in GMP documentation serves as evidence that a task was performed, reviewed, or approved by authorized personnel. Missing signatures are not just clerical errors—they are regulatory red...

The Importance of Controlled Copies in GMP Systems

digi — Sat, 13 Sep 2025 15:31:27 +0000

The Importance of Controlled Copies in GMP Systems Controlled Copies: A Cornerstone of GMP Documentation Systems Introduction: Why This Topic Matters for GMP Compliance In pharmaceutical manufacturing, every document used on the shop floor or in laboratories must be authentic, current, and traceable. Controlled copies—official versions of Standard Operating Procedures (SOPs), batch records, logbooks, and...